Phocas Financial’s Denali Therapeutics DNLI Stock Holding History
Bought
Maintained
Sold
Other funds holding DNLI
Phocas Financial's DNLI Position: Q3 2026 in Review
Phocas Financial sold out of Denali Therapeutics (DNLI) in Q3 2026, closing a stake of 71,197 shares — an estimated $1.83M sold.
Phocas Financial first reported a position in DNLI in Q2 2026 and held it in 1 quarter. The position peaked at $1.83M in Q2 2026. 286 funds tracked by Wall St. Rank hold DNLI as of Q3 2026.
- Phocas Financial reported no remaining Denali Therapeutics position as of Q3 2026 after selling out during the quarter.
- Phocas Financial sold 71,197 Denali Therapeutics shares in Q3 2026, an estimated $1.83M.
- Phocas Financial first reported a position in Denali Therapeutics in Q2 2026 and held it in 1 quarter.
- Phocas Financial's Denali Therapeutics position peaked at $1.83M in Q2 2026.
- 286 funds tracked by Wall St. Rank held Denali Therapeutics as of Q3 2026.
Based on Phocas Financial's 13F filing for Q3 2026.